Full Text (PDF)
Original Article

Helios III: Indian Experience with Avantgarde Innovative Fractional Q-Switched ND: YAG Laser

Sidharth Sonthalia, Consultant Dermatologist & Dermatosurgeon, Skinnocence: The Skin Clinic & Research Centre, Sushant Lok-1, Gurugram, Haryana 122002, India , Amarendra Pandey* , Sidharth Sonthalia** , Biplav Agarwal***

Author Information

Licence:




RFP Journal of Dermatology 2(2):p 57-61, Jul-Dec 2017. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Laser toning using low-fluence 1064-nm QSNY is being increasingly used to target photoaging and hyperpigmentation in darker skin types. However, sub-optimal response stemming from the use of low-fluences, as well as development of complications especially punctate leukoderma are also being increasingly reported with this approach. Since the development of the fractional- lasers, the fractional mode has been successfully incorporated with QS Nd: YAG (QSNY) laser (1064 nm) systems. Fractional mode lasers have the advantage of sparing certain areas in between the treated areas called microscopic treatment zones (MTZs), allowing for rapid healing, shorter recovery times, and less post-inflammatory complications. In this case series, we report our experience of a novel US-FDA approved fractional QSNY laser device Helios III in the treatment of various cutaneous lesions disorders in Indian patients including melanocytic nevi, atrophic scars, pigmented scars, laser hair reduction, reduction of white hair, melasma, and toe nail onychomycosis.

Keywords: Fractional Laser; Q-Switched; Nd:YAG; 1024 NM; Scars; Melasma; Hair Reduction.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Monday 26 January 2026, 19:09:22 (IST)


35

Accesses

0
4
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share